Sorry, this entry is only available in Ukrainian.
Відродження після кризи: майбутні стратегії компаній у фармацевтичній галузі
Вас может заинтересовать:
WEB only
The Syntegon Group, a provider of processing and packaging technology, appointed Torsten Türling as new Chief Executive Officer (CEO). He succeeds Dr. Michael Grosse, who will leave the company by…
WEB only
The EMA has launched a consultation on the circumstances in which single-arm trials (SATs) – those without a control group – can be used to support marketing applications for medicines…
